SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001387131-20-001537
Filing Date
2020-02-13
Accepted
2020-02-13 16:08:14
Documents
1
Group Members
ALTIUM GROWTH FUND, LPALTIUM GROWTH GP, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13G xbio-sc13ga_123119.htm SC 13G/A 115100
  Complete submission text file 0001387131-20-001537.txt   116834
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Subject) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89709 | Film No.: 20610513
SIC: 2834 Pharmaceutical Preparations

Mailing Address 551 FIFTH AVE - FL 19 NEW YORK NY 10176
Business Address 551 FIFTH AVE - FL 19 NEW YORK NY 10176 2124842711
Altium Capital Management LP (Filed by) CIK: 0001746382 (see all company filings)

IRS No.: 822066653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A